Maynard Um
-
-
-
-
-
-
-
Enliven Therapeutics (ELVN) PT Lowered to $78 at Guggenheim
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Enliven Therapeutics (ELVN)
-
-
-
-
-
-
-
Enliven Therapeutics names Rick Fair as new CEO
-
-
-
-
-
-
-
Enliven Therapeutics, Inc (ELVN) Prices 8.39M Share Offering at $19.66/sh
-
-
-
-
-
-
-
Enliven Therapeutics, Inc (ELVN) announces updated positive data from Phase 1 ELVN-001 trial
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Enliven Therapeutics (ELVN)
-
-
-
-
-
-
-
Baird Starts Enliven Therapeutics (ELVN) at Outperform
471,087 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


